Register Now

It has been long recognised that as an important stakeholder of global health security, the pharma sector needs to embrace sustainability as one of its tenets. But, it has faced allegations in the past of not shouldering its responsibility towards the environment. For instance, a report titled, ‘Carbon footprint of the global pharmaceutical industry and relative impact of its major players,’ reveals that the pharma industry is 55 per cent more emission-intensive than the automotive industry.

Therefore, whether it is implementing efficient processes through optimal utilisation of resources, ensuring regulatory compliance, developing tailored programmes to eliminate inefficiencies in their supply chain, better waste disposal systems, implementing measures to conserve energy and water, reducing carbon footprint or constructing greener buildings and facilities, there is a lot of scope for the pharma sector to ramp up its efforts towards being more environment-friendly. This calls for a change in vision, strategies, management practices, and operations in pharma organisations.

Therefore, in this session, as part of the Industry Knowledge Exchange Series, organised by Express Pharma, in association with SAP, leaders and experts will come together to examine initiatives taken by India Pharma Inc on sustainability so far and discuss its readiness and roadmap to comply with existing and upcoming regulations. For instance, SEBI’s new mandate to the top 1,000 listed companies by market cap to provide details of their material environmental, social, governance risks opportunities and strategies to alleviate or adapt to the risks along with financial implications under a new business responsibility and sustainability report (BRSR) format by 2023.

It will also look at the role of technology in enabling pharma organisations to comply with such regulations as well as monitor and maximise their sustainability footprint.

Why Attend :
+ Gain insights from thought leaders on evolution and adoption of sustainable practices in the pharma industry
+ Discuss risk-mitigation strategies to tackle environmental, social, end governance issues that challenge sustainability initiatives
+ Take a deeper dive into evolving regulations to check and minimise environmental impacts
+ Learn how to create an agile, flexible workforce across functions that thinks ‘systems and sustainability’